Ultimately, the authors conclude that early autoimmunity may reflect or result from advanced cellular aging; however, these conclusions are limited by lack of specificity concerning the racial composition of the cohort, as well as a small sample size

Ultimately, the authors conclude that early autoimmunity may reflect or result from advanced cellular aging; however, these conclusions are limited by lack of specificity concerning the racial composition of the cohort, as well as a small sample size. Our study has several limitations. proportion of non-Hispanic black participants (7.8% vs. 17.9%) experienced shortened telomeres (p<0.001). Shortened telomeres were not independently associated with ANA seropositivity (OR 1.48, 95% CI 0.87C2.52, p=0.14). However, female sex (OR 1.91, 95% CI 1.23C2.96, p=0.006), age 80 years (OR 2.06, 95% CI 1.08C3.92, p=0.03), and African American race (OR 1.58, 95% CI 1.00C2.51, p=0.05) were indie risk factors for ANA seropositivity. Neither sex nor race modified the relationship between ANA seropositivity and telomere size. Summary. Telomere erosion does not look like responsible for age-related raises in the prevalence of ANA seropositivity. Keywords: AZD8186 antinuclear antibodies, telomeres, ageing Intro Antinuclear antibodies (ANAs) are associated with autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, ANA seropositivity can exist in the absence of systemic rheumatologic disease. Among healthy adults, the prevalence of ANA seropositivity tends to increase with age (1). In one study, 19% of individuals aged 70 years or older were found to have detectable ANAs compared to 13% of individuals aged 20 to 39 years (1) Despite this improved expression, elderly individuals have not been shown to have a higher prevalence of most autoimmune diseases (2). Telomeres are specialised constructions in the ends of chromosomes that naturally shorten with age (3). They may be comprised of repeating AGGGTT nucleotide sequences and protect against genomic instability and eventual apoptosis and immunosenescence (3, 4). Therefore, telomere size essentially serves as a marker of biological aging with important functional effects (3, 5). Telomere size has been linked to a number of autoimmune diseases, including SLE and RA (6C10). Much of this study to day suggests that autoimmune disease likely predates measurably significant telomere shortening, indicating that telomere erosion may be consequential as opposed to causative. Whether an increase in the prevalence of ANA seropositivity among older healthy adults coincides with markers of biological aging such as telomere length remains largely unknown. A recent small longitudinal study shown an association between baseline PSG1 telomere size and event ANA seropositivity. The authors concluded that early autoimmunity may reflect or result from advanced cellular ageing (11). This discussion counters findings from an earlier study AZD8186 in which shortened telomeres were not associated with improved risk for event autoimmune disease (6). The purpose of our study was to determine whether telomere AZD8186 size was independently associated with ANA seropositivity among subjects enrolled in the National Health and Nourishment Examination Survey (NHANES) between the years 1999 and 2002. Methods Study design and patient human population We performed a cross-sectional study of results generated from NHANES, which comprises studies representative of the non-institutionalised U.S. human population. Survey data are collected in two-year cycles utilising a multistage probability sampling design (12). Measurement of leukocyte telomere size (LTL) was performed during years 1999C2002. Throughout this timeframe, NHANES oversampled a number of specific subgroups to produce more exact estimations, including individuals age groups 60 and older, African People in america, Mexican People in america, AZD8186 and low-income individuals. Subjects were considered eligible for our analysis if they were at least 20 years older and experienced both telomere size and ANA data available. Antinuclear antibody screening Standard immunofluorescence ANA screening was performed using commercial HEp-2 ANA slides with 1:80 dilutions of sera, followed by staining with DyLight 488-conjugated donkey anti-human IgG (-chain specific) antibodies (13). Cellular patterns of staining and staining intensities were characterised using previously explained classification AZD8186 methods (14). Immunofluorescence staining intensities were.